Writer Anne Fletcher has written a piece describing a change in the U.S. Food and Drug Administration’s (FDA) criteria for an acceptable outcome in the treatment of alcohol abuse.  As Fletcher notes:

… [the] FDA issued an official draft to guide development of drugs for the treatment of “alcoholism” that allows not only for abstinence as an outcome of studies showing efficacy of medications for their approval for clinical use but also allowing for a pattern of reduced drinking – described as “no heavy drinking days” – as an outcome.

(Many thanks to our reader Laura for drawing our attention to this).